chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: tired all day; headache that came and went; chills; fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired all day), HEADACHE (headache that came and went), CHILLS (chills) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced FATIGUE (tired all day), HEADACHE (headache that came and went), CHILLS (chills) and PYREXIA (fever). At the time of the report, FATIGUE (tired all day) and HEADACHE (headache that came and went) had not resolved and CHILLS (chills) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, Body temperature: 99.5.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site rash
Clinical narrative: The injection site area red; The injection site area raised; Vaccination site pruritus; small bumps on arm / rash is 6 inches in diameter; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (small bumps on arm / rash is 6 inches in diameter), VACCINATION SITE ERYTHEMA (The injection site area red), VACCINATION SITE INDURATION (The injection site area raised) and VACCINATION SITE PRURITUS (Vaccination site pruritus) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE RASH (small bumps on arm / rash is 6 inches in diameter) and VACCINATION SITE PRURITUS (Vaccination site pruritus). On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (The injection site area red) and VACCINATION SITE INDURATION (The injection site area raised). At the time of the report, VACCINATION SITE RASH (small bumps on arm / rash is 6 inches in diameter), VACCINATION SITE ERYTHEMA (The injection site area red), VACCINATION SITE INDURATION (The injection site area raised) and VACCINATION SITE PRURITUS (Vaccination site pruritus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Anosmia, COVID-19, Diarrhoea, Headache
Clinical narrative: Tested positive for covid, Headache, Minimum loss of smell, Minimum loss of taste, Abdominal pain, Back pain, Diarrhea; Headache; loss of smell; Abdominal pain; Diarrhea; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Tested positive for covid, Headache, Minimum loss of smell, Minimum loss of taste, Abdominal pain, Back pain, Diarrhea), HEADACHE (Headache), ANOSMIA (loss of smell), ABDOMINAL PAIN (Abdominal pain) and DIARRHOEA (Diarrhea) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced HEADACHE (Headache), ANOSMIA (loss of smell), ABDOMINAL PAIN (Abdominal pain) and DIARRHOEA (Diarrhea). On an unknown date, the patient experienced COVID-19 (Tested positive for covid, Headache, Minimum loss of smell, Minimum loss of taste, Abdominal pain, Back pain, Diarrhea). At the time of the report, COVID-19 (Tested positive for covid, Headache, Minimum loss of smell, Minimum loss of taste, Abdominal pain, Back pain, Diarrhea) outcome was unknown and HEADACHE (Headache), ANOSMIA (loss of smell), ABDOMINAL PAIN (Abdominal pain) and DIARRHOEA (Diarrhea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Limb discomfort, Vaccination site pain
Clinical narrative: Legs felt heavy; Left arm was sore; felt tired, fatigue; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Legs felt heavy), VACCINATION SITE PAIN (Left arm was sore) and FATIGUE (felt tired, fatigue) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included Migraine since an unknown date.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced LIMB DISCOMFORT (Legs felt heavy), VACCINATION SITE PAIN (Left arm was sore) and FATIGUE (felt tired, fatigue). At the time of the report, LIMB DISCOMFORT (Legs felt heavy), VACCINATION SITE PAIN (Left arm was sore) and FATIGUE (felt tired, fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: Positive for COVID-19; severe fatigue; severe brain fog; hyperventilated and had trouble breathing; hyperventilated and had trouble breathing; abdominal pain; Pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive for COVID-19), HYPERVENTILATION (hyperventilated and had trouble breathing), DYSPNOEA (hyperventilated and had trouble breathing), ABDOMINAL PAIN (abdominal pain) and VACCINATION SITE PAIN (Pain in the arm) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced HYPERVENTILATION (hyperventilated and had trouble breathing), DYSPNOEA (hyperventilated and had trouble breathing), ABDOMINAL PAIN (abdominal pain) and VACCINATION SITE PAIN (Pain in the arm). On 09-Jan-2021, the patient experienced FATIGUE (severe fatigue) and FEELING ABNORMAL (severe brain fog). On 20-Jan-2021, the patient experienced COVID-19 (Positive for COVID-19). At the time of the report, COVID-19 (Positive for COVID-19), HYPERVENTILATION (hyperventilated and had trouble breathing), DYSPNOEA (hyperventilated and had trouble breathing), ABDOMINAL PAIN (abdominal pain), VACCINATION SITE PAIN (Pain in the arm), FATIGUE (severe fatigue) and FEELING ABNORMAL (severe brain fog) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperventilation, Vaccination site pain
Clinical narrative: Positive for COVID-19; severe fatigue; severe brain fog; hyperventilated and had trouble breathing; hyperventilated and had trouble breathing; abdominal pain; Pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive for COVID-19), HYPERVENTILATION (hyperventilated and had trouble breathing), DYSPNOEA (hyperventilated and had trouble breathing), ABDOMINAL PAIN (abdominal pain) and VACCINATION SITE PAIN (Pain in the arm) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced HYPERVENTILATION (hyperventilated and had trouble breathing), DYSPNOEA (hyperventilated and had trouble breathing), ABDOMINAL PAIN (abdominal pain) and VACCINATION SITE PAIN (Pain in the arm). On 09-Jan-2021, the patient experienced FATIGUE (severe fatigue) and FEELING ABNORMAL (severe brain fog). On 20-Jan-2021, the patient experienced COVID-19 (Positive for COVID-19). At the time of the report, COVID-19 (Positive for COVID-19), HYPERVENTILATION (hyperventilated and had trouble breathing), DYSPNOEA (hyperventilated and had trouble breathing), ABDOMINAL PAIN (abdominal pain), VACCINATION SITE PAIN (Pain in the arm), FATIGUE (severe fatigue) and FEELING ABNORMAL (severe brain fog) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: pain in arm; skin reaction on arm red; skin reaction on arm swollen; skin reaction on arm itch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in arm), VACCINATION SITE ERYTHEMA (skin reaction on arm red), VACCINATION SITE SWELLING (skin reaction on arm swollen) and VACCINATION SITE PRURITUS (skin reaction on arm itch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain in arm), VACCINATION SITE ERYTHEMA (skin reaction on arm red), VACCINATION SITE SWELLING (skin reaction on arm swollen) and VACCINATION SITE PRURITUS (skin reaction on arm itch). At the time of the report, VACCINATION SITE PAIN (pain in arm), VACCINATION SITE ERYTHEMA (skin reaction on arm red), VACCINATION SITE SWELLING (skin reaction on arm swollen) and VACCINATION SITE PRURITUS (skin reaction on arm itch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (her arm is very sore and she can not even raise it) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 012L20A) for COVID-19 vaccination. The patient's past medical history included no adverse event. On Feb 17, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 17, 2021, patient experienced vaccination site pain (her arm is very sore and she can not even raise it). At the time of the report, vaccination site pain (her arm is very sore and she can not even raise it) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present, Vaccination site pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching) and BLOOD URINE PRESENT (last night started urinating blood and still going on) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included FOLIC ACID, LOVASTATIN, LOSARTAN, APIXABAN (ELIQUIS), METOPROLOL SUCCINATE and FESOTERODINE FUMARATE (TOVIAZ) for an unknown indication.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced BLOOD URINE PRESENT (last night started urinating blood and still going on). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching). At the time of the report, VACCINATION SITE PRURITUS (Itching) outcome was unknown and BLOOD URINE PRESENT (last night started urinating blood and still going on) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Body aches; chills; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (Body aches) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced MYALGIA (Body aches) and CHILLS (chills). At the time of the report, MYALGIA (Body aches) and CHILLS (chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: NNI
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Headache; fever Registered a 102F Temperature Taken on Neck; Body fatigue; arm/joint pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (fever Registered a 102F Temperature Taken on Neck), FATIGUE (Body fatigue), ARTHRALGIA (arm/joint pain) and CHILLS (chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HEADACHE (Headache), PYREXIA (fever Registered a 102F Temperature Taken on Neck), FATIGUE (Body fatigue), ARTHRALGIA (arm/joint pain) and CHILLS (chills). At the time of the report, HEADACHE (Headache), PYREXIA (fever Registered a 102F Temperature Taken on Neck), FATIGUE (Body fatigue), ARTHRALGIA (arm/joint pain) and CHILLS (chills) had not resolved. Possible    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature: 102 102F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache; fever Registered a 102F Temperature Taken on Neck; Body fatigue; arm/joint pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (fever Registered a 102F Temperature Taken on Neck), FATIGUE (Body fatigue), ARTHRALGIA (arm/joint pain) and CHILLS (chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HEADACHE (Headache), PYREXIA (fever Registered a 102F Temperature Taken on Neck), FATIGUE (Body fatigue), ARTHRALGIA (arm/joint pain) and CHILLS (chills). At the time of the report, HEADACHE (Headache), PYREXIA (fever Registered a 102F Temperature Taken on Neck), FATIGUE (Body fatigue), ARTHRALGIA (arm/joint pain) and CHILLS (chills) had not resolved. Possible    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature: 102 102F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Headache, Myalgia, Vaccination site pain
Clinical narrative: diarrhea; sick of the stomach; headache; pain in hte "Cheekbutts"; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), VACCINATION SITE PAIN (sore arm), ABDOMINAL DISCOMFORT (sick of the stomach), HEADACHE (headache) and MYALGIA (pain in hte "Cheekbutts") in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 20-Feb-2021, the patient experienced DIARRHOEA (diarrhea), ABDOMINAL DISCOMFORT (sick of the stomach), HEADACHE (headache) and MYALGIA (pain in hte "Cheekbutts"). At the time of the report, DIARRHOEA (diarrhea), VACCINATION SITE PAIN (sore arm), ABDOMINAL DISCOMFORT (sick of the stomach), HEADACHE (headache) and MYALGIA (pain in hte "Cheekbutts") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Big rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Big rash at the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 09-Feb-2012, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE RASH (Big rash at the injection site). At the time of the report, VACCINATION SITE RASH (Big rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperglycaemia, Sluggishness, Vaccination site pain
Clinical narrative: sluggish; blood sugar rose each day; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (blood sugar rose each day), VACCINATION SITE PAIN (Arm pain) and SLUGGISHNESS (sluggish) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus.    On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm pain). On 25-Jan-2021, the patient experienced HYPERGLYCAEMIA (blood sugar rose each day). On an unknown date, the patient experienced SLUGGISHNESS (sluggish). On 22-Jan-2021, VACCINATION SITE PAIN (Arm pain) had resolved. At the time of the report, HYPERGLYCAEMIA (blood sugar rose each day) and SLUGGISHNESS (sluggish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Feeling of body temperature change, Headache
Clinical narrative: Slight Cough; hot and cold; headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Slight Cough), FEELING OF BODY TEMPERATURE CHANGE (hot and cold) and HEADACHE (headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced COUGH (Slight Cough), FEELING OF BODY TEMPERATURE CHANGE (hot and cold) and HEADACHE (headache). At the time of the report, COUGH (Slight Cough), FEELING OF BODY TEMPERATURE CHANGE (hot and cold) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical information).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash). At the time of the report, VACCINATION SITE RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Ear disorder, Ear pain, Hypoacusis, Tinnitus, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Experiencing hearing loss), EAR PAIN (Pain in ears), TINNITUS (Ear ringing), VACCINATION SITE SWELLING (Mild swelling at injection site) and EAR DISORDER (Pressure in ears) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042220A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history reported).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced HYPOACUSIS (Experiencing hearing loss), EAR PAIN (Pain in ears), TINNITUS (Ear ringing), VACCINATION SITE SWELLING (Mild swelling at injection site) and EAR DISORDER (Pressure in ears). At the time of the report, HYPOACUSIS (Experiencing hearing loss), EAR PAIN (Pain in ears), TINNITUS (Ear ringing), VACCINATION SITE SWELLING (Mild swelling at injection site) and EAR DISORDER (Pressure in ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: itch; rash; fatigue; Vaccination site pain; injection site bump; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itch), VACCINATION SITE RASH (rash), FATIGUE (fatigue), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE INDURATION (injection site bump) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cataract (Surgery scheduled on 27-JAN-2021).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itch), VACCINATION SITE RASH (rash), FATIGUE (fatigue), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE INDURATION (injection site bump). At the time of the report, VACCINATION SITE PRURITUS (itch), VACCINATION SITE RASH (rash), FATIGUE (fatigue), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE INDURATION (injection site bump) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchy; Red; Red rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE RASH (Red rash around the injection site) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0301420A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history was reported.).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE RASH (Red rash around the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE RASH (Red rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site discolouration, Pain in extremity
Clinical narrative: Pinkish spot on her arm around the injection site; Arm became sore; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (Pinkish spot on her arm around the injection site) and PAIN IN EXTREMITY (Arm became sore) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0326204) for COVID-19 vaccination.     Concomitant products included LISINOPRIL for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced INJECTION SITE DISCOLOURATION (Pinkish spot on her arm around the injection site) and PAIN IN EXTREMITY (Arm became sore). At the time of the report, INJECTION SITE DISCOLOURATION (Pinkish spot on her arm around the injection site) had not resolved and PAIN IN EXTREMITY (Arm became sore) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Depressed mood, Pain, Sleep disorder
Clinical narrative: pain from her neck to her arm; unable to sleep; feels down; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain from her neck to her arm), SLEEP DISORDER (unable to sleep) and DEPRESSED MOOD (feels down) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0136204) for COVID-19 vaccination.     Concomitant products included THYROID, MULTIVITAMINS, PLAIN and FOLIC ACID for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN (pain from her neck to her arm), SLEEP DISORDER (unable to sleep) and DEPRESSED MOOD (feels down). At the time of the report, PAIN (pain from her neck to her arm), SLEEP DISORDER (unable to sleep) and DEPRESSED MOOD (feels down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site plaque, Injection site pruritus, Injection site rash
Clinical narrative: injection site itching; rough patich (on top of inj site); clear rash,little bubbles; large circular place; hard; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INDURATION (large circular place; hard), INJECTION SITE PRURITUS (injection site itching), INJECTION SITE PLAQUE (rough patich (on top of inj site)) and INJECTION SITE RASH (clear rash,little bubbles) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L02A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE INDURATION (large circular place; hard). On an unknown date, the patient experienced INJECTION SITE PRURITUS (injection site itching), INJECTION SITE PLAQUE (rough patich (on top of inj site)) and INJECTION SITE RASH (clear rash,little bubbles). At the time of the report, INJECTION SITE INDURATION (large circular place; hard), INJECTION SITE PRURITUS (injection site itching), INJECTION SITE PLAQUE (rough patich (on top of inj site)) and INJECTION SITE RASH (clear rash,little bubbles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: both sides of her arms were itchy; A spontaneous report was received from a consumer, concerning herself a female patient of age 42 years, who had received her first dose on (23-Jan-2021) Moderna's COVID-19 and experienced both arms itchy.  The patient's medical history includes hypertension and asthma, concomitant medication was not provided by reporter.  On 23 Jan 2021 patient received her first dose of two planned doses of mRNA-1273 (lot number:0121204) via unknown route for COVID-19 infection prophylaxis.  On 23 Jan 2021 she experienced her arms were itchy and  indicated that she ate shrimp a week later and experienced the same reaction but has no history but being allergic shrimp.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event both arms itchy was not resolved at time of reporting.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm was hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was hurting) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was hurting). At the time of the report, PAIN IN EXTREMITY (Arm was hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Vomiting
Clinical narrative: vomiting phlegm; difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing) and VOMITING (vomiting phlegm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included Hypothyroidism and Multiple sclerosis. Concurrent medical conditions included Allergy to topical drugs (Allergies to aspirin, penicillin and gadolinium). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and Jelena for an unknown indication.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DYSPNOEA (difficulty breathing). On 27-Jan-2021, the patient experienced VOMITING (vomiting phlegm). At the time of the report, DYSPNOEA (difficulty breathing) and VOMITING (vomiting phlegm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchiness at the site of the injection; Swelling at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness at the site of the injection) and VACCINATION SITE SWELLING (Swelling at the site of the injection) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031ML0A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness at the site of the injection) and VACCINATION SITE SWELLING (Swelling at the site of the injection). At the time of the report, VACCINATION SITE PRURITUS (Itchiness at the site of the injection) and VACCINATION SITE SWELLING (Swelling at the site of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Head discomfort, Limb discomfort, Pain in extremity
Clinical narrative: trouble getting out of bed; pain in his arm; head felt weird; wobbly on his feet; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (trouble getting out of bed), PAIN IN EXTREMITY (pain in his arm), HEAD DISCOMFORT (head felt weird) and LIMB DISCOMFORT (wobbly on his feet) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced DYSSTASIA (trouble getting out of bed), PAIN IN EXTREMITY (pain in his arm), HEAD DISCOMFORT (head felt weird) and LIMB DISCOMFORT (wobbly on his feet). At the time of the report, DYSSTASIA (trouble getting out of bed), PAIN IN EXTREMITY (pain in his arm), HEAD DISCOMFORT (head felt weird) and LIMB DISCOMFORT (wobbly on his feet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up document was received. The outcome of adverse event was updated to recovered/resolved. It contains significant information.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: injection site redness; Injection site swelling; injection site swelling; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection site swelling), INJECTION SITE ERYTHEMA (injection site redness) and INJECTION SITE SWELLING (Injection site swelling) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concomitant products included MELATONIN for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced INJECTION SITE SWELLING (injection site swelling). On 25-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (injection site redness) and INJECTION SITE SWELLING (Injection site swelling). On 22-Jan-2021, INJECTION SITE SWELLING (injection site swelling) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (injection site redness) and INJECTION SITE SWELLING (Injection site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: injection site pain/his arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (injection site pain/his arm was sore) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced INJECTION SITE PAIN (injection site pain/his arm was sore). At the time of the report, INJECTION SITE PAIN (injection site pain/his arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Hordeolum
Clinical narrative: Sty in her eye; This spontaneous case was reported by a consumer and describes the occurrence of HORDEOLUM (Sty in her eye) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HORDEOLUM (Sty in her eye). At the time of the report, HORDEOLUM (Sty in her eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Pain, Peripheral swelling, Vaccination site bruising
Clinical narrative: still has a bruise; itching; then had hives; entire upper arm started to swell; painful; chills; felt like she got stung by a bee; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching), VACCINATION SITE URTICARIA (then had hives), PERIPHERAL SWELLING (entire upper arm started to swell), PAIN (painful) and CHILLS (chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to insect sting.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching), VACCINATION SITE URTICARIA (then had hives), PERIPHERAL SWELLING (entire upper arm started to swell), PAIN (painful), CHILLS (chills) and FEELING ABNORMAL (felt like she got stung by a bee). On 27-Jan-2021, the patient experienced VACCINATION SITE BRUISING (still has a bruise). At the time of the report, VACCINATION SITE PRURITUS (itching), VACCINATION SITE URTICARIA (then had hives), PAIN (painful), CHILLS (chills), FEELING ABNORMAL (felt like she got stung by a bee) and VACCINATION SITE BRUISING (still has a bruise) outcome was unknown and PERIPHERAL SWELLING (entire upper arm started to swell) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: still has a bruise; itching; then had hives; entire upper arm started to swell; painful; chills; felt like she got stung by a bee; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching), VACCINATION SITE URTICARIA (then had hives), PERIPHERAL SWELLING (entire upper arm started to swell), PAIN (painful) and CHILLS (chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to insect sting.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching), VACCINATION SITE URTICARIA (then had hives), PERIPHERAL SWELLING (entire upper arm started to swell), PAIN (painful), CHILLS (chills) and FEELING ABNORMAL (felt like she got stung by a bee). On 27-Jan-2021, the patient experienced VACCINATION SITE BRUISING (still has a bruise). At the time of the report, VACCINATION SITE PRURITUS (itching), VACCINATION SITE URTICARIA (then had hives), PAIN (painful), CHILLS (chills), FEELING ABNORMAL (felt like she got stung by a bee) and VACCINATION SITE BRUISING (still has a bruise) outcome was unknown and PERIPHERAL SWELLING (entire upper arm started to swell) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH (Patient has a rash after getting the Moderna covid shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced RASH (Patient has a rash after getting the Moderna covid shot). At the time of the report, RASH (Patient has a rash after getting the Moderna covid shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site rash
Clinical narrative: Sore shoulder; Small rash; This spontaneous case was reported by an other caregiver and describes the occurrence of ARTHRALGIA (Sore shoulder) and VACCINATION SITE RASH (Small rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Sore shoulder) and VACCINATION SITE RASH (Small rash). At the time of the report, ARTHRALGIA (Sore shoulder) and VACCINATION SITE RASH (Small rash) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-017446 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-017446:same reorter, different patient
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles from neck to the top of head after first shot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Shingles from neck to the top of head after first shot) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LOSARTAN for Hypertension, APIXABAN (ELIQUIS) for Thrombus.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jan-2021, the patient experienced HERPES ZOSTER (Shingles from neck to the top of head after first shot). At the time of the report, HERPES ZOSTER (Shingles from neck to the top of head after first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-017250 (E2B Linked Report).; Sender's Comments:  MOD-2021-017250:Same patient, second dose
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: swollen vaccination site; warmth at vaccination site; tender; became red around the injection site; itching at vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at vaccination site), VACCINATION SITE ERYTHEMA (became red around the injection site), VACCINATION SITE SWELLING (swollen vaccination site), VACCINATION SITE WARMTH (warmth at vaccination site) and VACCINATION SITE PAIN (tender) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical history provided.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at vaccination site). On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (became red around the injection site). On an unknown date, the patient experienced VACCINATION SITE SWELLING (swollen vaccination site), VACCINATION SITE WARMTH (warmth at vaccination site) and VACCINATION SITE PAIN (tender). At the time of the report, VACCINATION SITE PRURITUS (itching at vaccination site), VACCINATION SITE ERYTHEMA (became red around the injection site), VACCINATION SITE SWELLING (swollen vaccination site), VACCINATION SITE WARMTH (warmth at vaccination site) and VACCINATION SITE PAIN (tender) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided/unknown by the reporter.    Event treatment: Not specified.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Influenza like illness, Myalgia, Oropharyngeal pain
Clinical narrative: Sore throat; Chills; Body aches; Like the flu; Not feeling too good, felt bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Not feeling too good, felt bad), OROPHARYNGEAL PAIN (Sore throat), CHILLS (Chills), MYALGIA (Body aches) and INFLUENZA LIKE ILLNESS (Like the flu) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K0A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus and Blood pressure high.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced FEELING ABNORMAL (Not feeling too good, felt bad), MYALGIA (Body aches) and INFLUENZA LIKE ILLNESS (Like the flu). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and CHILLS (Chills). At the time of the report, FEELING ABNORMAL (Not feeling too good, felt bad), OROPHARYNGEAL PAIN (Sore throat), CHILLS (Chills), MYALGIA (Body aches) and INFLUENZA LIKE ILLNESS (Like the flu) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications reported included medications for type 2 diabetes and high blood pressure.  Treatment for the events included one Tylenol  500 extra (acetaminophen).   Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: Additional info on events.